Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pressure Enabled Drug Delivery By Pancreatic Retrograde Venous Infusion For Advanced Pancreatic Carcinoma

NCT04270929 is registered in ClinicalTrials.gov with Roger Williams Medical Center as lead sponsor.

NCT NCT04270929
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04270929 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pressure Enabled Drug Delivery By Pancreatic Retrograde Venous Infusion For Advanced Pancreatic Carcinoma
Lead sponsor
Roger Williams Medical Center
Phase
Phase 1
Overall status
Withdrawn
Start date
December 23, 2019
Completion date
May 4, 2021
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pancreatic adenocarcinoma